Pliant Therapeutics Q4 EPS $(0.38) Beats $(0.41) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.77 percent. This is a 53.66 percent increase over losses of $(0.82) per share
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.77 percent. This is a 53.66 percent increase over losses of $(0.82) per share from the same period last year.